IBDEI08D ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11063,1,3,0)
 ;;=3^Iris Atrophy,Other
 ;;^UTILITY(U,$J,358.3,11063,1,4,0)
 ;;=4^364.59
 ;;^UTILITY(U,$J,358.3,11063,2)
 ;;=Iris Atrophy^268731
 ;;^UTILITY(U,$J,358.3,11064,0)
 ;;=224.0^^55^616^11
 ;;^UTILITY(U,$J,358.3,11064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11064,1,3,0)
 ;;=3^Benign Neopl of Iris
 ;;^UTILITY(U,$J,358.3,11064,1,4,0)
 ;;=4^224.0
 ;;^UTILITY(U,$J,358.3,11064,2)
 ;;=^267670
 ;;^UTILITY(U,$J,358.3,11065,0)
 ;;=364.72^^55^616^6
 ;;^UTILITY(U,$J,358.3,11065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11065,1,3,0)
 ;;=3^Anterior Synechiae
 ;;^UTILITY(U,$J,358.3,11065,1,4,0)
 ;;=4^364.72
 ;;^UTILITY(U,$J,358.3,11065,2)
 ;;=Anterior Synechiae^265517
 ;;^UTILITY(U,$J,358.3,11066,0)
 ;;=364.71^^55^616^102
 ;;^UTILITY(U,$J,358.3,11066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11066,1,3,0)
 ;;=3^Posterior Synechiae
 ;;^UTILITY(U,$J,358.3,11066,1,4,0)
 ;;=4^364.71
 ;;^UTILITY(U,$J,358.3,11066,2)
 ;;=Posterior Synechiae^265519
 ;;^UTILITY(U,$J,358.3,11067,0)
 ;;=364.00^^55^616^57
 ;;^UTILITY(U,$J,358.3,11067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11067,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,11067,1,4,0)
 ;;=4^364.00
 ;;^UTILITY(U,$J,358.3,11067,2)
 ;;=Iridocyclitis, Acute^268703
 ;;^UTILITY(U,$J,358.3,11068,0)
 ;;=379.40^^55^616^106
 ;;^UTILITY(U,$J,358.3,11068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11068,1,3,0)
 ;;=3^Pupil, Abnormal function
 ;;^UTILITY(U,$J,358.3,11068,1,4,0)
 ;;=4^379.40
 ;;^UTILITY(U,$J,358.3,11068,2)
 ;;=Pupil, Abnormal function^101288
 ;;^UTILITY(U,$J,358.3,11069,0)
 ;;=190.0^^55^616^84
 ;;^UTILITY(U,$J,358.3,11069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11069,1,3,0)
 ;;=3^Malig Neopl of Eyeball,Iris
 ;;^UTILITY(U,$J,358.3,11069,1,4,0)
 ;;=4^190.0
 ;;^UTILITY(U,$J,358.3,11069,2)
 ;;=Malig Neopl of Iris^267271
 ;;^UTILITY(U,$J,358.3,11070,0)
 ;;=190.3^^55^616^83
 ;;^UTILITY(U,$J,358.3,11070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11070,1,3,0)
 ;;=3^Malig Neopl Conjunctiva
 ;;^UTILITY(U,$J,358.3,11070,1,4,0)
 ;;=4^190.3
 ;;^UTILITY(U,$J,358.3,11070,2)
 ;;=Malig Neopl Conjunctiva^267274
 ;;^UTILITY(U,$J,358.3,11071,0)
 ;;=364.41^^55^616^50
 ;;^UTILITY(U,$J,358.3,11071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11071,1,3,0)
 ;;=3^Hyphema
 ;;^UTILITY(U,$J,358.3,11071,1,4,0)
 ;;=4^364.41
 ;;^UTILITY(U,$J,358.3,11071,2)
 ;;=Hyphema^60498
 ;;^UTILITY(U,$J,358.3,11072,0)
 ;;=364.05^^55^616^51
 ;;^UTILITY(U,$J,358.3,11072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11072,1,3,0)
 ;;=3^Hypopyon
 ;;^UTILITY(U,$J,358.3,11072,1,4,0)
 ;;=4^364.05
 ;;^UTILITY(U,$J,358.3,11072,2)
 ;;=Hypopion^60720
 ;;^UTILITY(U,$J,358.3,11073,0)
 ;;=365.02^^55^616^4
 ;;^UTILITY(U,$J,358.3,11073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11073,1,3,0)
 ;;=3^Angle, Narrow
 ;;^UTILITY(U,$J,358.3,11073,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,11073,2)
 ;;=Angle, Narrow^268748
 ;;^UTILITY(U,$J,358.3,11074,0)
 ;;=372.63^^55^616^117
 ;;^UTILITY(U,$J,358.3,11074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11074,1,3,0)
 ;;=3^Symblepharon
 ;;^UTILITY(U,$J,358.3,11074,1,4,0)
 ;;=4^372.63
 ;;^UTILITY(U,$J,358.3,11074,2)
 ;;=Symblepharon^265885
 ;;^UTILITY(U,$J,358.3,11075,0)
 ;;=372.75^^55^616^27
 ;;^UTILITY(U,$J,358.3,11075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11075,1,3,0)
 ;;=3^Cysts, Conjunctival
 ;;^UTILITY(U,$J,358.3,11075,1,4,0)
 ;;=4^372.75
 ;;^UTILITY(U,$J,358.3,11075,2)
 ;;=Cysts, Conjunctival^269049
 ;;^UTILITY(U,$J,358.3,11076,0)
 ;;=364.81^^55^616^43
 ;;^UTILITY(U,$J,358.3,11076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11076,1,3,0)
 ;;=3^Floppy Iris Syndrome
 ;;^UTILITY(U,$J,358.3,11076,1,4,0)
 ;;=4^364.81
 ;;^UTILITY(U,$J,358.3,11076,2)
 ;;=^335254
 ;;^UTILITY(U,$J,358.3,11077,0)
 ;;=006.9^^55^616^2
 ;;^UTILITY(U,$J,358.3,11077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11077,1,3,0)
 ;;=3^Amebiasis
 ;;^UTILITY(U,$J,358.3,11077,1,4,0)
 ;;=4^006.9
 ;;^UTILITY(U,$J,358.3,11077,2)
 ;;=^5818
 ;;^UTILITY(U,$J,358.3,11078,0)
 ;;=190.8^^55^616^60
 ;;^UTILITY(U,$J,358.3,11078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11078,1,3,0)
 ;;=3^Iris Melanoma,Contiguous Site
 ;;^UTILITY(U,$J,358.3,11078,1,4,0)
 ;;=4^190.8
 ;;^UTILITY(U,$J,358.3,11078,2)
 ;;=^267278
 ;;^UTILITY(U,$J,358.3,11079,0)
 ;;=224.1^^55^616^93
 ;;^UTILITY(U,$J,358.3,11079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11079,1,3,0)
 ;;=3^Orbit Neoplasm,Benign
 ;;^UTILITY(U,$J,358.3,11079,1,4,0)
 ;;=4^224.1
 ;;^UTILITY(U,$J,358.3,11079,2)
 ;;=^267671
 ;;^UTILITY(U,$J,358.3,11080,0)
 ;;=360.33^^55^616^52
 ;;^UTILITY(U,$J,358.3,11080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11080,1,3,0)
 ;;=3^Hypotony,Assoc w/ Ocular D/O
 ;;^UTILITY(U,$J,358.3,11080,1,4,0)
 ;;=4^360.33
 ;;^UTILITY(U,$J,358.3,11080,2)
 ;;=^268560
 ;;^UTILITY(U,$J,358.3,11081,0)
 ;;=224.8^^55^616^86
 ;;^UTILITY(U,$J,358.3,11081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11081,1,3,0)
 ;;=3^Neopl Eye Bgn,Oth Iris Nevus
 ;;^UTILITY(U,$J,358.3,11081,1,4,0)
 ;;=4^224.8
 ;;^UTILITY(U,$J,358.3,11081,2)
 ;;=^267678
 ;;^UTILITY(U,$J,358.3,11082,0)
 ;;=364.01^^55^616^103
 ;;^UTILITY(U,$J,358.3,11082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11082,1,3,0)
 ;;=3^Prim Iridocyclitis
 ;;^UTILITY(U,$J,358.3,11082,1,4,0)
 ;;=4^364.01
 ;;^UTILITY(U,$J,358.3,11082,2)
 ;;=^268704
 ;;^UTILITY(U,$J,358.3,11083,0)
 ;;=364.04^^55^616^53
 ;;^UTILITY(U,$J,358.3,11083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11083,1,3,0)
 ;;=3^Iridociclyties 2ary,Non Infectious
 ;;^UTILITY(U,$J,358.3,11083,1,4,0)
 ;;=4^364.04
 ;;^UTILITY(U,$J,358.3,11083,2)
 ;;=^268710
 ;;^UTILITY(U,$J,358.3,11084,0)
 ;;=364.21^^55^616^46
 ;;^UTILITY(U,$J,358.3,11084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11084,1,3,0)
 ;;=3^Fuch's Hetero Cyclitis
 ;;^UTILITY(U,$J,358.3,11084,1,4,0)
 ;;=4^364.21
 ;;^UTILITY(U,$J,358.3,11084,2)
 ;;=^48468
 ;;^UTILITY(U,$J,358.3,11085,0)
 ;;=364.23^^55^616^81
 ;;^UTILITY(U,$J,358.3,11085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11085,1,3,0)
 ;;=3^Lens-Induced Iridocyclitis
 ;;^UTILITY(U,$J,358.3,11085,1,4,0)
 ;;=4^364.23
 ;;^UTILITY(U,$J,358.3,11085,2)
 ;;=^268713
 ;;^UTILITY(U,$J,358.3,11086,0)
 ;;=364.51^^55^616^8
 ;;^UTILITY(U,$J,358.3,11086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11086,1,3,0)
 ;;=3^Atrophy Iris Essential/Progressive
 ;;^UTILITY(U,$J,358.3,11086,1,4,0)
 ;;=4^364.51
 ;;^UTILITY(U,$J,358.3,11086,2)
 ;;=^268718
 ;;^UTILITY(U,$J,358.3,11087,0)
 ;;=364.53^^55^616^100
 ;;^UTILITY(U,$J,358.3,11087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11087,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,11087,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,11087,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,11088,0)
 ;;=364.57^^55^616^33
 ;;^UTILITY(U,$J,358.3,11088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11088,1,3,0)
 ;;=3^Degen Ciliary Body Changes
 ;;^UTILITY(U,$J,358.3,11088,1,4,0)
 ;;=4^364.57
 ;;^UTILITY(U,$J,358.3,11088,2)
 ;;=^268728
 ;;^UTILITY(U,$J,358.3,11089,0)
 ;;=364.60^^55^616^26
 ;;^UTILITY(U,$J,358.3,11089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11089,1,3,0)
 ;;=3^Cyst,Idiopathic
 ;;^UTILITY(U,$J,358.3,11089,1,4,0)
 ;;=4^364.60
 ;;^UTILITY(U,$J,358.3,11089,2)
 ;;=^268733
 ;;^UTILITY(U,$J,358.3,11090,0)
 ;;=364.73^^55^616^97
 ;;^UTILITY(U,$J,358.3,11090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11090,1,3,0)
 ;;=3^Peripheral Ant Synechiae
 ;;^UTILITY(U,$J,358.3,11090,1,4,0)
 ;;=4^364.73
 ;;^UTILITY(U,$J,358.3,11090,2)
 ;;=^268740
 ;;^UTILITY(U,$J,358.3,11091,0)
 ;;=364.75^^55^616^107
 ;;^UTILITY(U,$J,358.3,11091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11091,1,3,0)
 ;;=3^Pupillary Abnormalities
 ;;^UTILITY(U,$J,358.3,11091,1,4,0)
 ;;=4^364.75
 ;;^UTILITY(U,$J,358.3,11091,2)
 ;;=^268742
 ;;^UTILITY(U,$J,358.3,11092,0)
 ;;=364.76^^55^616^58
 ;;^UTILITY(U,$J,358.3,11092,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11092,1,3,0)
 ;;=3^Iridodialysis
 ;;^UTILITY(U,$J,358.3,11092,1,4,0)
 ;;=4^364.76
 ;;^UTILITY(U,$J,358.3,11092,2)
 ;;=^265499
 ;;^UTILITY(U,$J,358.3,11093,0)
 ;;=364.77^^55^616^3
 ;;^UTILITY(U,$J,358.3,11093,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11093,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,11093,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,11093,2)
 ;;=^268743
 ;;^UTILITY(U,$J,358.3,11094,0)
 ;;=364.89^^55^616^62
 ;;^UTILITY(U,$J,358.3,11094,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11094,1,3,0)
 ;;=3^Iris/Ciliary D/O,Other
 ;;^UTILITY(U,$J,358.3,11094,1,4,0)
 ;;=4^364.89
 ;;^UTILITY(U,$J,358.3,11094,2)
 ;;=^268745
 ;;^UTILITY(U,$J,358.3,11095,0)
 ;;=364.9^^55^616^61
 ;;^UTILITY(U,$J,358.3,11095,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11095,1,3,0)
 ;;=3^Iris/Ciliary Body D/O,Unspec
 ;;^UTILITY(U,$J,358.3,11095,1,4,0)
 ;;=4^364.9
 ;;^UTILITY(U,$J,358.3,11095,2)
 ;;=^123847
 ;;^UTILITY(U,$J,358.3,11096,0)
 ;;=370.00^^55^616^25
 ;;^UTILITY(U,$J,358.3,11096,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11096,1,3,0)
 ;;=3^Corneal Ulcer NOS
 ;;^UTILITY(U,$J,358.3,11096,1,4,0)
 ;;=4^370.00
 ;;^UTILITY(U,$J,358.3,11096,2)
 ;;=^28441
 ;;^UTILITY(U,$J,358.3,11097,0)
 ;;=370.20^^55^616^66
 ;;^UTILITY(U,$J,358.3,11097,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11097,1,3,0)
 ;;=3^Keratitis,Superfic Unspec
 ;;^UTILITY(U,$J,358.3,11097,1,4,0)
 ;;=4^370.20
 ;;^UTILITY(U,$J,358.3,11097,2)
 ;;=^268918
 ;;^UTILITY(U,$J,358.3,11098,0)
 ;;=370.31^^55^616^99
 ;;^UTILITY(U,$J,358.3,11098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11098,1,3,0)
 ;;=3^Phlyctenule Keratoconj
 ;;^UTILITY(U,$J,358.3,11098,1,4,0)
 ;;=4^370.31
 ;;^UTILITY(U,$J,358.3,11098,2)
 ;;=^268928^017.30
 ;;^UTILITY(U,$J,358.3,11099,0)
 ;;=370.8^^55^616^65
 ;;^UTILITY(U,$J,358.3,11099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11099,1,3,0)
 ;;=3^Keratitis,Oth Forms
 ;;^UTILITY(U,$J,358.3,11099,1,4,0)
 ;;=4^370.8
 ;;^UTILITY(U,$J,358.3,11099,2)
 ;;=^87595
